In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lancôme marketing

This article was originally published in The Rose Sheet

Executive Summary

Toria Garrett to VP-marketing for fragrance, sun and body, L'Oréal division announces. Exec will oversee U.S. marketing and advertising development for brand's sun and body products, as well as fragrances, including Miracle, Miracle for Men and Trésor, firm says. Garrett joined L'Oréal in 1995, working most recently as assistant VP of treatment marketing. Elana Drell-Szyfer will succeed Garrett, overseeing marketing and advertising initiatives for Lancôme's skin care products including Renergie, Vinefit, Primordiale and Absolue. She most recently worked as assistant VP of marketing for fragrance, sun and body after joining L'Oréal in 1993...

You may also be interested in...



Iterum Anxiously Awaiting Other Results After SURE 3 Failure

Iterum’s antibiotic sulopenem missed its endpoint by the equivalent of one patient. The company believes the Phase III data could still support its NDA for urinary tract infections.

FDA Gives Sponsors A New Tool To Prove MRI-Compatibility

The US FDA has qualified a new modeling tool that could give sponsors more assurance that their products meet the agency’s expectations for MRI-compatibility.

Sanofi's €10bn Dupixent Plan: "We're Going To Put The JAKs Properly In Their Place"

Sanofi's new CEO has ambitious forecasts for Dupixent in atopic dermatitis, asthma and other indications. The French pharma outlined how it plans to reach that goal despite new competition vying to get in.

UsernamePublicRestriction

Register

RS010375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel